Medline’s ReadyPrep™ CHG cloths hit 40+ percent domestic market share in two years
Antiseptic products a popular new choice for pre-op skin antiseptic solutions
By Medline Newsroom Staff | May 24, 2021
Surgical site infections are the costliest healthcare-associated infection with an estimated annual cost of $3.3 billion according to the CDC¹. Within two years of launching a pre-op skin antiseptic cloth designed to help give clinicians another tool to fight SSIs called ReadyPrep™CHG, it has captured more than 40 percent of domestic market share.
Medline launched the chlorhexidine gluconate-dosed cloths in 2019 after years of clinical trials, review and final approval by the FDA. The pre-op skin antiseptic cloths quickly gained popularity with hospital groups across the nation because of their competitive cost, larger cloth and a two-year long shelf life.
It’s just one of the many products manufactured in the United States with solution created at the company’s Hartland, Wisc. plant and then dosed and produced in Waukegan, Illinois.
“We made a very deliberate decision to invest in domestic manufacturing to meet ongoing time-to-market demands,” said Stu Schneider, Personal Care group president of Medline. “This strategy is paying off as we are on pace to clinch 45 percent of the domestic market share by end of year.”
Dedicated to domestic
This is just one of the many investments made as part of the Medline North American Manufacturing Expansion (NAME). In 2020, the company announced plans to manufacture face masks in North America for the first time. The company modified its Lithia Springs, Ga. plant to produce 36 million face masks per month.
In addition, Medline launched hand sanitizer production at its Hartland, Wis. plant to help meet a nationwide shortage. Medline redeployed manufacturing capabilities in that facility to produce the 80 percent ethyl alcohol-based hand sanitizer and retrofitted one of its production rooms for the new product.
Over this time, more than $10 million was invested in manufacturing capital expenditures, R&D, and clinical trials to bring the ReadyPrep™CHG solution to market.
Skin, nose and mouth kits
Product teams continue to evolve and grow their infection prevention portfolio. To provide consistent, safe and effective delivery of antiseptic to the three main sources of bacteria – skin, nose and mouth – Medline has created Total Prep System kits with pre-saturated povidone iodine nasal antiseptic swabs, CHG oral rinse and CHG cloths to help reduce risks of SSIs.
“The kits provide healthcare workers an easy and convenient way to reduce risks of surgical site infections,” said Nikki Cracknell, medical science liaison at Medline. “These prep system kits are key to a successful decolonization strategy and can reduce the time for a hospital patient’s stay by more than nine days.¹”
Learn more about Medline’s infection prevention solutions.
- Loyola University Health System. Surgical site infections are the most common and costly of hospital infections